Similar articles

• [The role of dialysis membranes in elimination of uremic toxins].

  Grzeszczak W, Zukowska-Szczechowska E, Rutkowski B. Grzeszczak W, et al. Przegl Lek. 1996;53(5):439-42. Przegl Lek. 1996. PMID: 8754410 Review. Polish. No abstract available.
• Bioincompatible membranes place patients with acute renal failure at increased risk of infection.

  Shaldon S. Shaldon S. ASAIO J. 1996 Nov-Dec;42(6):1032-3. ASAIO J. 1996. PMID: 8959281 No abstract available.
• Are standards and checklists needed in uremia therapy?

  Shaldon S, Koch KM. Shaldon S, et al. Kidney Int Suppl. 1985 Dec;17:S124-6. Kidney Int Suppl. 1985. PMID: 3867781 No abstract available.
• Blood level of middle molecular substances during uraemia and haemodialysis.

  Dzúrik R, Bozek P, Reznícek J, Oborníková A. Dzúrik R, et al. Proc Eur Dial Transplant Assoc. 1973;10(0):263-70. Proc Eur Dial Transplant Assoc. 1973. PMID: 4802412 No abstract available.
• Dialyzer reuse--part II: advantages and disadvantages.

  Twardowski ZJ. Twardowski ZJ. Semin Dial. 2006 May-Jun;19(3):217-26. doi: 10.1111/j.1525-139X.2006.00158.x. Semin Dial. 2006. PMID: 16689973 Review.